132 related articles for article (PubMed ID: 17161064)
1. Association of torsades de pointes with novel and known single nucleotide polymorphisms in long QT syndrome genes.
Mank-Seymour AR; Richmond JL; Wood LS; Reynolds JM; Fan YT; Warnes GR; Milos PM; Thompson JF
Am Heart J; 2006 Dec; 152(6):1116-22. PubMed ID: 17161064
[TBL] [Abstract][Full Text] [Related]
2. Gene symbol: SCN5A.
Crotti L; Ferrandi C; Insolia R; Pedrazzini M; Tosin L; Veia A; Turco A; De Ferrari GM; Schwartz PJ
Hum Genet; 2007 Feb; 120(6):911-2. PubMed ID: 17438607
[No Abstract] [Full Text] [Related]
3. Ketoconazole induced torsades de pointes without concomitant use of QT interval-prolonging drug.
Mok NS; Lo YK; Tsui PT; Lam CW
J Cardiovasc Electrophysiol; 2005 Dec; 16(12):1375-7. PubMed ID: 16403073
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced long QT syndrome and torsade de pointes.
Morissette P; Hreiche R; Turgeon J
Can J Cardiol; 2005 Aug; 21(10):857-64. PubMed ID: 16107909
[TBL] [Abstract][Full Text] [Related]
5. Drug-induced QT-interval prolongation and recurrent torsade de pointes in a child with heterotaxy syndrome and KCNE1 D85N polymorphism.
Lin L; Horigome H; Nishigami N; Ohno S; Horie M; Sumazaki R
J Electrocardiol; 2012; 45(6):770-3. PubMed ID: 22999324
[TBL] [Abstract][Full Text] [Related]
6. New mechanism contributing to drug-induced arrhythmia: rescue of a misprocessed LQT3 mutant.
Liu K; Yang T; Viswanathan PC; Roden DM
Circulation; 2005 Nov; 112(21):3239-46. PubMed ID: 16301357
[TBL] [Abstract][Full Text] [Related]
7. A presumably benign human ether-a-go-go-related gene mutation (R176W) with a malignant primary manifestation of long QT syndrome.
Donner BC; Marschall C; Schmidt KG
Cardiol Young; 2012 Jun; 22(3):360-3. PubMed ID: 22067087
[TBL] [Abstract][Full Text] [Related]
8. Sex differences in ventricular repolarization: from cardiac electrophysiology to Torsades de Pointes.
Abi-Gerges N; Philp K; Pollard C; Wakefield I; Hammond TG; Valentin JP
Fundam Clin Pharmacol; 2004 Apr; 18(2):139-51. PubMed ID: 15066127
[TBL] [Abstract][Full Text] [Related]
9. Exome sequencing implicates an increased burden of rare potassium channel variants in the risk of drug-induced long QT interval syndrome.
Weeke P; Mosley JD; Hanna D; Delaney JT; Shaffer C; Wells QS; Van Driest S; Karnes JH; Ingram C; Guo Y; Shyr Y; Norris K; Kannankeril PJ; Ramirez AH; Smith JD; Mardis ER; Nickerson D; George AL; Roden DM
J Am Coll Cardiol; 2014 Apr; 63(14):1430-7. PubMed ID: 24561134
[TBL] [Abstract][Full Text] [Related]
10. Novel KCNE3 mutation reduces repolarizing potassium current and associated with long QT syndrome.
Ohno S; Toyoda F; Zankov DP; Yoshida H; Makiyama T; Tsuji K; Honda T; Obayashi K; Ueyama H; Shimizu W; Miyamoto Y; Kamakura S; Matsuura H; Kita T; Horie M
Hum Mutat; 2009 Apr; 30(4):557-63. PubMed ID: 19306396
[TBL] [Abstract][Full Text] [Related]
11. Post myocardial ischemia-associated torsades de pointes in a patient carrying a KCNQ1 G643S variant.
Nakajima T; Kaneko Y; Saito A; Irie T; Kato T; Iso T; Kurabayashi M
Intern Med; 2010; 49(23):2587-91. PubMed ID: 21139297
[TBL] [Abstract][Full Text] [Related]
12. Antidepressants: their effects on cardiac channels, QT prolongation and Torsade de Pointes.
Sala M; Coppa F; Cappucciati C; Brambilla P; d'Allio G; Caverzasi E; Barale F; De Ferrari GM
Curr Opin Investig Drugs; 2006 Mar; 7(3):256-63. PubMed ID: 16555686
[TBL] [Abstract][Full Text] [Related]
13. Gene symbol: SCN5A.
Crotti L; Ferrandi C; Insolia R; Pedrazzini M; Andreoli E; Veia A; Crimi G; Agnetti A; De Ferrari GM; Schwartz PJ
Hum Genet; 2007 Feb; 120(6):913. PubMed ID: 17438610
[No Abstract] [Full Text] [Related]
14. The genetic basis of long QT and short QT syndromes: a mutation update.
Hedley PL; Jørgensen P; Schlamowitz S; Wangari R; Moolman-Smook J; Brink PA; Kanters JK; Corfield VA; Christiansen M
Hum Mutat; 2009 Nov; 30(11):1486-511. PubMed ID: 19862833
[TBL] [Abstract][Full Text] [Related]
15. Low penetrance, subclinical congenital LQTS: concealed LQTS or silent LQTS?
Varró A; Papp JG
Cardiovasc Res; 2006 Jun; 70(3):404-6. PubMed ID: 16678140
[No Abstract] [Full Text] [Related]
16. A novel KCNQ1 variant (L203P) associated with torsades de pointes-related syncope in a Steinert syndrome patient.
Patoine D; Hasibu I; Pilote S; Champagne J; Drolet B; Simard C
Can J Cardiol; 2011; 27(2):263.e5-12. PubMed ID: 21459285
[TBL] [Abstract][Full Text] [Related]
17. [Long-QT caused by drugs and torsade de pointes: a genetic basis?].
Schwartz PJ
Cardiologia; 1999 Dec; 44 Suppl 1(Pt 1):277-9. PubMed ID: 12497921
[No Abstract] [Full Text] [Related]
18. Torsades de pointes during complete atrioventricular block: Genetic factors and electrocardiogram correlates.
Subbiah RN; Gollob MH; Gula LJ; Davies RW; Leong-Sit P; Skanes AC; Yee R; Klein GJ; Krahn AD
Can J Cardiol; 2010 Apr; 26(4):208-12. PubMed ID: 20386770
[TBL] [Abstract][Full Text] [Related]
19. Common genetic variants in ANK2 modulate QT interval: results from the KORA study.
Sedlacek K; Stark K; Cunha SR; Pfeufer A; Weber S; Berger I; Perz S; Kääb S; Wichmann HE; Mohler PJ; Hengstenberg C; Jeron A
Circ Cardiovasc Genet; 2008 Dec; 1(2):93-9. PubMed ID: 20031550
[TBL] [Abstract][Full Text] [Related]
20. Citalopram induced torsade de pointes, a rare life threatening side effect.
Kanjanauthai S; Kanluen T; Chareonthaitawee P
Int J Cardiol; 2008 Dec; 131(1):e33-4. PubMed ID: 17919753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
